- Home
- MURA vs UONE Comparison
MURA vs UONE Comparison
Compare MURA & UONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- UONE
- Stock Information
- Founded
- MURA 2013
- UONE 1980
- Country
- MURA Ireland
- UONE United States
- Employees
- MURA N/A
- UONE N/A
- Industry
- MURA
- UONE Broadcasting
- Sector
- MURA
- UONE Consumer Discretionary
- Exchange
- MURA Nasdaq
- UONE Nasdaq
- Market Cap
- MURA 57.2M
- UONE 65.7M
- IPO Year
- MURA N/A
- UONE N/A
- Fundamental
- Price
- MURA $3.34
- UONE $1.67
- Analyst Decision
- MURA Strong Buy
- UONE
- Analyst Count
- MURA 4
- UONE 0
- Target Price
- MURA $16.00
- UONE N/A
- AVG Volume (30 Days)
- MURA 270.3K
- UONE 79.3K
- Earning Date
- MURA 11-13-2024
- UONE 11-12-2024
- Dividend Yield
- MURA N/A
- UONE N/A
- EPS Growth
- MURA N/A
- UONE N/A
- EPS
- MURA N/A
- UONE N/A
- Revenue
- MURA N/A
- UONE $452,891,000.00
- Revenue This Year
- MURA N/A
- UONE N/A
- Revenue Next Year
- MURA N/A
- UONE N/A
- P/E Ratio
- MURA N/A
- UONE N/A
- Revenue Growth
- MURA N/A
- UONE N/A
- 52 Week Low
- MURA $2.88
- UONE $1.23
- 52 Week High
- MURA $6.25
- UONE $4.29
- Technical
- Relative Strength Index (RSI)
- MURA 36.64
- UONE 54.09
- Support Level
- MURA $3.32
- UONE $1.47
- Resistance Level
- MURA $4.20
- UONE $1.70
- Average True Range (ATR)
- MURA 0.23
- UONE 0.15
- MACD
- MURA -0.08
- UONE 0.01
- Stochastic Oscillator
- MURA 3.41
- UONE 57.14
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About UONE Urban One Inc.
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.